Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00956163 Information provided by National Cancer Institute (NCI)
First Received on August 7, 2009. Last Updated on May 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Metastases
Recurrent Prostate Cancer
Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer
Additional conditions recognized in this trial
Bone Marrow Diseases
Bone Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
Prostatic Neoplasms
More general conditions related to this trial
Bone Diseases
Genital Diseases, Male
Genital Neoplasms, Male
Hematologic Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
magnetic resonance imaging
fluorine F 18 sodium fluoride
Additional drug interventions recognized in this trial
Diphosphonates
Fluorides
Methylene diphosphonate
Sodium Fluoride
More general drug interventions related to this trial
Bone Density Conservation Agents
Cariostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
